DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the NARAYANA HRUDAYALAYA LTD. (NH) share price today?

NARAYANA HRUDAYALAYA LTD. (NH) is trading at ₹2,029.5 on the NSE, down 0.26% on the day. Source: DocStoX.

What is the PE ratio of NARAYANA HRUDAYALAYA LTD.?

NARAYANA HRUDAYALAYA LTD. has a price-to-earnings (PE) ratio of 51.5 in the Healthcare sector.

What is the market capitalisation of NARAYANA HRUDAYALAYA LTD.?

NARAYANA HRUDAYALAYA LTD. has a market capitalisation of approximately ₹41,464 crore.

NARAYANA HRUDAYALAYA LTD.

NH·NSE·Healthcare

₹2,029.50▼ -5.30 (-0.26%)

Healthcare · Hospitals

Revenue compounding 20% a year

NIFTY 500NIFTY SMALLCAP 250

Day₹2004.00

₹2043.00

52W₹1589

₹209387%

Open

₹2038.00

High

₹2043.00

Low

₹2004.00

Prev Close

₹2034.80

Volume

1.67L

VWAP

₹2023.78

Snapshot

Key fundamentals

Market Cap

₹41,464 Cr

P/E Ratio

51.48Expensive

P/B Ratio

8.96

EPS

₹39.42

Book Value

₹222.00

ROE

20.90%Strong

ROCE

15.00%Decent

Dividend Yield

0.23%

Debt / Equity

1.29Elevated

Face Value

₹10.00

52W High

₹2093.30

52W Low

₹1589.00

Sector

Healthcare

Industry

Hospitals

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹327

▼ 83.9%downside

Trading at ₹2,030 — 84% above our estimate

BearFair valueBull

₹278₹327₹444

/100

Business quality — Watch the fundamentals

Growth 61Profitability 63Efficiency 18Valuation 18

Plain English

Our view

Revenue compounding 20% a year
Strong returns on equity (21%)
Fundamental red flags (Piotroski 1/9)

Strengths

Strong returns on equity (21%)
Revenue compounding 20% over 3 years
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

21% ROE fading to 14% over ~10 yrs, on ₹222 book

₹295

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹444

Analyst target

No analyst coverage

—

Blended fair value₹327

What the numbers say

Investment thesis

Bull case

Strong returns on equity (21%)
Revenue compounding 20% over 3 years
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

51.5Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

20.9%Strong

Above 15% is considered healthy for Indian equities

ROCE

15.0%Decent

Above 18% means capital is working hard

Debt/Eq

1.29Elevated

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹41,464 Cr

P/B

8.96

EPS

₹39.42

Div Yield

0.23%

What changed

Recent changes

Foreign investors-1.1% stake last quarter
Domestic institutions+1.2% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 51.5×

Growth

Strong

+20% rev CAGR

Profitability

Excellent

20.9% ROE

Financial health

Leveraged

D/E 1.29

Momentum

N/A

No technicals

Today

Trading activity

Delivery %61.8%

Turnover₹3383.89L Cr

Trades17,610

VWAP₹2023.78

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+20.4%

+25.0%

10Y

+17.2%

Profit

+9.9%

—

10Y

+44.0%

EPS

+9.9%

—

10Y

+43.8%

Profile

Pros

Company is expected to give good quarter
Company has a good return on equity (ROE) track record: 3 Years ROE 24.7%

Watch-outs

Cons

Stock is trading at 9.13 times its book value
Company might be capitalizing the interest cost

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 1.12 pts; domestic institutions added 1.24 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

63%

Promoter

Promoters

63.3%0.00

Public

10.6%-0.34

FII / FPI

10.0%-1.12

DII

9.2%+1.24

Others

7.0%

Total shareholders

2,20,561-7,562 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter63.27%

FII9.98%

DII9.15%

Public10.64%

Others6.96%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]